In Vivo is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Advanced Life Sciences Holdings, Inc.

http://www.advancedlifesciences.com

Latest From Advanced Life Sciences Holdings, Inc.

Epitel Gets 510(k) Clearance On Remote EEG Technology

The REMI Remote EEG monitoring system and REMI Vigilenz AI could help patients with infrequent seizures get a quicker diagnosis.

Approvals FDA

Takeda Charges Into Diversification With ITP Win

The company announced positive topline results from a Phase II study of mezagitamab and expects to have five programs in Phase III development this fiscal year.

Clinical Trials Business Strategies

Deal Watch: Biogen, AbCellera Team To Find Novel Way To Cross Blood-Brain Barrier

Plus deals involving BiomX/Adapative Phage, One/NEX-I, Shionogi/FunPep, Taiho/Haihe, Kinnate/Pierre Fabre, StemCell Technologies/SQZ and more, as well as tech transfer agreements.

Deal Watch Business Strategies

Sanofi Ramps Up In Rare Diseases With Inhibrx Buy

The French major is paying up to $2.2bn to get access to Inhibrx’s alpha-1 antitrypsin deficiency candidate and to take a stake in the rest of the California-based biotech’s portfolio.

M & A Rare Diseases
See All

Company Information

  • Industry
  • Biotechnology
  • Pharmaceuticals
UsernamePublicRestriction

Register